Bladder cancer is the most common cancer in the urological tract. Here, we investigated the molecular pathways involved in the apoptosis of rodent bladder cancer, which was treated with Bifidobacterium infantis (BI)-mediated herpes simplex virus thymidine kinase (HSV-TK)/ganciclovir (GCV) suicide gene therapy. We engineered the BI-TK system, which consists of BI with the recombinant plasmid PGEX-1lT carrying HSV-TK (that is, TK) gene. Tumor-bearing rats were randomly divided into three groups and tail vein injected with normal saline (group A), BI/PGEX-1lT (group B) or BI-TK (group C), followed by intraperitoneal injection of GCV. The BI-TK/GCV system (group C) was shown to inhibit tumor growth and caused the apoptosis of tumor cells as assessed by in situ terminal transferase dUTP nick-end labeling assay. While varied extents of apoptosis were detected in tumor cells from all groups, tumor cells treated with BI-TK/GCV system (group C) exhibited the highest level of apoptosis (Po0.05), consistent with our previous studies. Furthermore, we found that the expression levels of Fas, FasL, Cyt-C and caspase-9 in tumor tissues derived from group C were significantly higher than the other two groups (Po0.001). Therefore, our results have demonstrated that the BI-TK/GCV therapy system exhibits a sustainable antitumor growth activity in the rodent model of bladder cancer. Mechanistically, both extrinsic and intrinsic apoptosis pathways are involved in the BI-TK/GCV antitumor functionality.
INTRODUCTION
Bladder cancer is the most common and deadly malignancy of all urological carcinomas. Its high incidence and mortality pose a great challenge and threat to the patients and public health. In order to combat the high recurrence rate of bladder cancer, gene therapy has been studied as potential alternative means for bladder cancer treatment, in addition to the conventional treatments, including surgery, chemotherapy and radiotherapy. However, the antitumor efficacy of cancer gene therapy remains to be improved.
Nonetheless, among all the potential gene therapies, herpes simplex virus thymidine kinase (HSV-TK)/ganciclovir (GCV) system has stood out as one of the most effective suicide gene therapis for malignant bladder tumor in animal models. 1, 2 Traditionally, the HSV-TK gene was carried by adenoviral vectors, which transduce both aberrant and normal cells. 3 The lack of specificity has hindered the optimization of its antitumor effect. In contrast, B. infantis (BI) system is tumor targeting because the bacterial cells are strictly anaerobic and capable of penetrating the outer layers of tumor mass to reach the central anaerobic region. 4, 5 Consequently, we and others have demonstrated that the BImediated HSV-TK/GCV system is an ideal approach for combating tumor growth. [6] [7] [8] [9] Our previous studies indicate that the BI-TK/GCV system can cause significant tumor shrinkage with an apparent apoptosis in the affected tumor cells. In this study, we investigate the molecular mechanisms underlying the BI-TK/GCV-induced tumor cell apoptosis. Our results show that the BI-TK/GCV is an efficacious suicide gene therapy of a rat model of bladder cancer, which is mediated by triggering both extrinsic and intrinsic apoptosis pathways in cancer cells.
University at the temperature 23-27 1C and humidity 55-65% with 12-h light-dark cycles. All animal procedures were approved by the Animal Use and Care Committee of Chongqing Medical University.
Methods
Amplification and purification of TK gene. DH5a cells containing plasmid PUC-TK was inoculated in a 6 ml LB medium with ampicillin 100 mg ml À 1 . Plasmid PUC-TK was isolated using Omega Bio-Tek plasmid extraction kits. The TK coding region was PCR amplified from PUC-TK using forward primer 5 0 -TATATAGGATCCATGGCTTCGTACCCC-3 0 and reverse primer 5 0 -GTATTAGA ATTCTCAG TTAGCCTCCCCCA-3 0 . The PCR program was as follows: 94 1C for 5 min, followed by 35 cycles of 94 1C Â 30 s, 57 1C Â 30 s and 72 1C Â 90 s. A final extension was performed at 72 1C for 90s.
Construction and transformation of plasmid pGEX-TK to make BI-TK system. The PCR-amplified HSV-TK gene was cloned into pGEX-1lT at Sal I and EcoR I sites to generate pGEX-TK, which was sequencing verified. Purified pGEX-TK was transformed into the electrocompetent BI, resulting in BI-TK by following the Pauwell's protocols. 4 The BI/PGEX-1lT vector control was generated in a similar fashion.
Establishment of a rat model of bladder cancer. N-methyl-nitrosourea perfusion was used to establish rat model of bladder tumor. We adopted N-methyl-N-nitrosourea with the concentration of 20 mg l À 1 and perfused 0.1 ml for each bladder, once every 2 weeks until a total of four times of perfusion were completed. Fifty-four tumor-bearing Sprague-Dawley rats were randomly divided into three groups (n ¼ 18 each): normal saline group, BI/PGEX-1lT group and BI-TK group. About 0.5 ml of the corresponding interventions were injected via tail vein, (bacterium count was 4.4 Â 10 9 ) once a week for 4 weeks. All groups received daily intraperitoneal injection of GCV (50 mg kg À 1 ) for 28 days.
Determination of total bladder weight. All rats were killed by cervix overextension, and necropsy was performed afterwards. The bladders were carefully dissected. The anterior wall was opened to observe the morphology of bladder tumors. The bladder was dried by filter papers and then weighed.
Apoptosis in bladder tumor cells detected by TUNEL assay. We followed the instructions of the terminal transferase dUTP nick-end labeling (TUNEL) kits. Paraffin-embedded tissue sections were pretreated according to our lab protocol. The tissue sections were deparaffinized and rehydrated through a graded series of ethanol and buffers. Tissue sections were incubated at 37 1C for 20 min with proteinase K (20 mg ml
) and rinsed three times with phosphate-buffered saline. The prepared tissue was incubated with 50 ml TUNEL reaction mixture for 60 min at 37 1C in the dark and analyzed under a fluorescence microscope. Then, 50 ml converter was added to the sample and incubated at 37 1C for 30 min. The samples were developed with diaminobenzidine, counterstained with hematoxylin and mounted with cover slides. Under a microscope, apoptotic cells were counted in three non-overlapping fields, with a total of 100 cells selected for each filed. Apoptosis index was calculated as the percentage of apoptosis cells over total counted cells.
Expressions of Fas, FasL, Cyt-C(cytosolic) and caspase-9 in tumor tissues detected by western blotting. Total cellular proteins or mitochondria proteins were extracted by following instructions of Tissue Mitochondria Isolation Kit and the reported procedures. 10 A 100-mg tumor tissue was extracted from bladder and homogenized in radioimmuno precipitation assay containing 10 ml of 10mgml À 1 phenylmethylsulfonyl fluoride solution. Cell supernatant lysate was collected by centrifuging at 44 1C for 15 min at 12 000 r.p.m. The protein concentrations of the recovered supernatants were analyzed using BCA Protein Assay Kit (Beyotime, Nantong, China). The cell lysate was boiled for 10 min in SDSpolyacrylamide gel electrophoresis sample loading buffer. Forty micrograms total proteins per well were subjected to SDSpolyacrylamide gel electrophoresis, followed by electrotransferring of the gel to nitrocellulose membranes. The membranes were blocked in non-fat dry milk for 1.5 h and probed with rabbit anti-GAPDH, Fas, FasL, Cyt-C and caspase-9 at a dilution ratio of 1:1000. The membranes were incubated at 4 1C overnight and rinsed with TBST for 10 min three times. The membranes were developed by ECL (Beyotime, Nantong, China) and imaged with the GEL imaging system (Bio-Rad, Hercules, CA, USA). The intensity and area of each target band and the GAPDH band were determined. Protein index was calculated as the percentage of target protein scanning value over GAPDH value.
Statistical analysis
The values of quantitative data were expressed as mean ± s.d. T-test was used to analyze the mean differences. Po0.05 was considered statistically significant. All the experimental data were analyzed using the SPSS19.0 software (IBM, Armonk, NY, USA).
RESULTS
Construction of the pGEX-TK vector The 1.1-kb PCR fragment containing HSV-TK gene was subcloned into the pGEX-1lT at EcoR I and Sal I sites. The recombinant plasmid was confirmed by PCR, and a DNA fragment in accordance with the length of HSV-TK gene was found. Sequencing analysis confirmed that the engineered vector was successfully constructed. The total size of pGEX-TK is 6.0 kb (Figure 1 ).
Verification of BI colonies
The transformed BI formed scattered colonies on the LB plates containing MRS medium and ampicillin. On the contrary, for BI without transformation, there were no colonies on the MRS ampicillin LB plates. Plasmid extracted from individual colonies was confirmed containing HSV-TK gene fragment (Figure 2) .
Establishment of the rat model of bladder cancer and treatment with BI-TK/GCV We started with 70 rats, 4 of which were discontinued in the process of N-methyl-N-nitrosourea infusion owing to urethrostenosis and 5 of which died during the process of tumor induction. We excluded three rats owing to the failure of tumor induction as assessed by ultrasound examination. A total of 54 tumor-bearing rats, confirmed by ultrasound, were randomized into three groups. The average weight of group NS, BI/PGEX-1lT and BI-TK was 248.9, 247.5 and 249.3 g, respectively. The post-therapy body weight of each group was 269.1 g for NS, 272.5 g for BI/PGEX-1lT and 282.2 g for BI-TK. However, Figure 3 shows that the bladder weight of BI-TK group was significantly lower than that of the normal saline group (Po0.001). However, no significant difference was observed between the normal saline group and the BI/PGEX1lT plasmid group (P40.05). 
Detection of apoptosis by TUNEL analysis
The apoptotic cells were stained with green fluorescent after TUNEL staining ( Figure 4 ). As shown in Figure 4 , the apoptosis potency in BI-TK group was much stronger than that in the normal saline group or BI/pGEX-1lT group. The apoptotic index of BI-TK (38.56±7.13%) was significantly higher than that of the normal saline group (15.78 ± 5.86%) or BI/pGEX-1lT (17.06 ± 5.89%) (Po0.001). However, the apoptotic index between the normal saline group and the pGEX-1lT plasmid group was not statistically different (P40.05).
Protein expressions of Fas, Fasl, Cyt-C(cytosolic) and caspase-9 by western blot analysis The protein expression indices of Fas/FasL, Cyc-c and caspase-9 in each group were tabulated in Table 1 . The protein expression levels of Fas, Fasl, Cyt-C and caspase-9 in pGEX-TK recombinant plasmid group were significantly higher than that in the normal saline group (Po0.05) and pGEX-1lT group (Po0.05). No statistically significant differences were obtained between normal saline group and pGEX-5X-1 group (P40.05) ( Figure 5 ).
DISCUSSION
In this study, we successfully constructed the pGEX-TK vector and transformed it into BI via electroporation. Upon BI-TK/GCV treatment, we found that the tumor volume and bladder weight decreased significantly. These results indicate that BI-mediated suicide gene therapy is effective to inhibit the progressive growth of bladder tumor. We also found that the apoptosis in BI-TK group was significantly greater than that of the other two groups, indicating that the BI-TK/GCV system may directly promote apoptosis and hence inhibit tumor growth. By comparing the levels of Fas/FasL, Cyt-C and caspase-9, we found that a combined action of both apoptosis pathways may be involved in BI-TK/GCV gene therapy. Numerous studies have reported that the apoptosis of tumor cells is closely related to the death receptor signaling pathway of Fas/FasL, 11, 12 while few studies focus on intrinsic apoptosis pathway mediated by mitochondria. Thus, our results suggest that a profound and complete activation of apoptosis by BI-TK system may be through multiple molecular signals.
Gene therapy is defined as transferring exogenous genes into human body to correct gene defects. 13 It is promising in cancer treatment because it may be used for etiological and/or the symptomatic remedies. The ideal genetic therapy is tumor-specific and immune tolerant. 9 Bifidobacterium is widely used in food industry. 14, 15 Because of the bacterial anaerobic feature, Bifidobacterium can proliferate in tumors through intravenous injection. Vaupel 16 found the partial pressure of oxygen of tumor central region was below 2.5 mm Hg while the normal tissue was 24-66 mm Hg. Thus, using BI as the vector, therapeutic gene will be effectively delivered to the very center of tumor, leading to tumor shrinkage. Furthermore, the bacteria cells also promote tumor cell apoptosis, which intensified the genetic function simultaneously. 8 Currently, BI carring target genes has been applied to many animal trials, including lung cancer, melanoma and hepatocellular carcinoma. [17] [18] [19] We have broadened its application in bladder tumor for the first time in 2009. 6 Previous and present studies have proved BI to be a reliable vector with sustainable safety as well. 17, 18 We further found that the weight of rats in BI-TK group (282.2 g) presented vague reduction vs that in NS group (269l.1 g), suggesting that no adverse effects have been associated with the use of BI on rats' health.
Suicide gene therapy may be used clinically among many gene therapeutic methods. 20, 21 HSV-TK/GCV system is one of the most widely used suicide gene therapy protocols in cancer gene therapy. 22, 23 Its possible mechanism is through induction of apoptosis in tumor cells. [24] [25] [26] The HSV-tk/GCV system may exert its antitumor function through two distinct effects. First, the suicide effect of the thymidine kinase HSV-tk gene is mediated by converting non-toxic GCV to hydroxide triphosphate (GCV-TP), which can cause mismatch of basis, breakage of DNA, exchange of sister chromatids and fatal instability of gene. 27, 28 Furthermore, GCV-TP can prevent DNA synthesis by blocking DNA polymerase. Second, a bystander effect may exist by causing gap junction disruption and releasing toxic metabolites. However, the exact mechanism of this suicide gene, especially in different tumors, remains to be thoroughly investigated. 29, 30 Our study has shed light on the molecular mechanism of the BI-TK system. We have demonstrated that both Fas/FasL/death receptor pathway and mitochondria pathway initiated with Cyt-C were involved. Nevertheless, in dose escalation studies, we could detect small differences. This phenomenon may be caused by the fact that one of the two pathways could be induced at the early stage and have a leading role of in the activation of apoptosis. Furthermore, we have demonstrated that BI can survive well inside tumor tissues and is capable of infecting tumor cells. It remains to be fully understood how the bacterial cells transduce tumor cells and escape from the influence of suicidal gene. We are interested in unraveling these unsolved mysteries in our future studies.
CONCLUSIONS BI-mediated HSV-TK/GCV suicide gene system exhibits effective antitumor activity, which is at least in part through the induction of both extrinsic and intrinsic apoptosis pathways in the affected tumor cells. 
